Theriva Biologics, Inc. Tax Adjustments, Settlements, and Unusual Provisions
Theriva Biologics, Inc. (TOVX) reported Tax Adjustments, Settlements, and Unusual Provisions of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2022-03-16
- Theriva Biologics, Inc. tax adjustments, settlements, and unusual provisions for fiscal 2021 was $0.00.
- Theriva Biologics, Inc. tax adjustments, settlements, and unusual provisions for fiscal 2020 was $0.00.
- Theriva Biologics, Inc. tax adjustments, settlements, and unusual provisions for fiscal 2018 was $19.00K.
- Theriva Biologics, Inc. tax adjustments, settlements, and unusual provisions for fiscal 2017 was -$2.00K.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-16 |
| 2018-12-31 | $19.00K 10-K · filed 2019-02-27 |
| 2017-12-31 | -$2.00K 10-K · filed 2019-02-27 |
| 2016-12-31 | -$431.00K 10-K · filed 2018-02-22 |
| 2015-12-31 | $199.00K 10-K · filed 2017-03-02 |
| 2014-12-31 | -$687.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |